Literature DB >> 25227804

Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.

Rajkumar Krishnan1, Dinesh Kumar Thayalan, Rajashree Padmanaban, Ramya Ramadas, Ramesh Kumar Annasamy, Nirmala Anandan.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is an important malignancy throughout the world; early detection is an important criterion for achieving high cure rate. Out of the many reported markers for OSCC, this study validated the efficacy of tumor necrosis factor-α (TNF- α) in differentially diagnosing premalignant oral lesions and OSCC. Also, the study aimed to correlate the levels of salivary and serum TNF- α with clinicopathologic factors.
MATERIALS AND METHODS: A prospective experimental laboratory study was designed. Serum and salivary samples from 100 subjects in each group of healthy control, premalignant disease (PMD) and OSCC were collected for the study following appropriate exclusion and inclusion criteria. Serum and salivary level of TNF-α was analysed by enzyme linked immunosorbent assay. The data obtained were subjected to appropriate statistical analysis.
RESULTS: Increased level of both serum and salivary TNF- α was observed in OSCC subjects compared to healthy control and PMD group. Receiver operator characteristic curve analysis and area under curve values showed high specificity and sensitivity for salivary TNF-α in differentiating OSCC from PMD and healthy controls. There was significant increase in TNF- α level in moderately and poorly differentiated lesion compared to well differentiated lesion and in stage IV of clinical stage. A positive correlation was observed only with histological grading of OSCC and TNF- α.
CONCLUSIONS: Salivary TNF-α is proved to be superior for detecting OSCC. Increase in TNF-α with histological grading and clinical staging suggests a role in prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227804     DOI: 10.7314/apjcp.2014.15.17.7141

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  20 in total

1.  Oral sampling methods are associated with differences in immune marker concentrations.

Authors:  Carole Fakhry; Fares Qeadan; Robert H Gilman; Pablo Yori; Margaret Kosek; Nicole Patterson; David W Eisele; Christine G Gourin; Chandala Chitguppi; Morgan Marks; Patti Gravitt
Journal:  Laryngoscope       Date:  2017-11-24       Impact factor: 3.325

2.  Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.

Authors:  Cristina Gurizzan; Luigi Lorini; Alberto Paderno; Michele Tomasoni; Gabriele Zigliani; Anna Bozzola; Laura Ardighieri; Simonetta Battocchio; Eliana Bignotti; Antonella Ravaggi; Chiara Romani; Loris De Cecco; Mara Serena Serafini; Rosalba Miceli; Elena Bardellini; Alessandra Majorana; Cesare Piazza; Paolo Bossi
Journal:  BMC Cancer       Date:  2021-05-17       Impact factor: 4.430

Review 3.  Saliva in the diagnosis of diseases.

Authors:  Chen-Zi Zhang; Xing-Qun Cheng; Ji-Yao Li; Ping Zhang; Ping Yi; Xin Xu; Xue-Dong Zhou
Journal:  Int J Oral Sci       Date:  2016-09-29       Impact factor: 6.344

4.  Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations

Authors:  Thayalan Dineshkumar; Balakuntla Krishnamurthy Ashwini; Annasamy Rameshkumar; Padmanaban Rajashree; Ramadas Ramya; Krishnan Rajkumar
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

5.  Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer.

Authors:  Yi-Zih Kuo; Wei-Yu Fang; Cheng-Chih Huang; Sen-Tien Tsai; Yi-Ching Wang; Chih-Li Yang; Li-Wha Wu
Journal:  Oncotarget       Date:  2017-02-28

Review 6.  Redirecting the focus of cancer immunotherapy to premalignant conditions.

Authors:  M Rita I Young
Journal:  Cancer Lett       Date:  2017-01-24       Impact factor: 8.679

Review 7.  Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Elena Ferrari; Margherita E Pezzi; Diana Cassi; Thelma A Pertinhez; Alberto Spisni; Marco Meleti
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

8.  Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections.

Authors:  Małgorzata Polz-Dacewicz; Małgorzata Strycharz-Dudziak; Jakub Dworzański; Agnieszka Stec; Joanna Kocot
Journal:  Infect Agent Cancer       Date:  2016-08-20       Impact factor: 2.965

9.  The inflammatory effects of TNF-α and complement component 3 on coagulation.

Authors:  Martin J Page; Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

10.  An exploratory approach demonstrating immune skewing and a loss of coordination among cytokines in plasma and saliva of Veterans with combat-related PTSD.

Authors:  Zhewu Wang; Howard Mandel; Corinne A Levingston; M Rita I Young
Journal:  Hum Immunol       Date:  2016-05-20       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.